Enovis Corporation

ENOV ·Healthcare, Medical Devices, United States
Financial Statements › Income Statement
Annual Quarterly

Income Statement

Line Item FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019 FY2018
Revenue $2.25B $2.11B $1.71B $1.56B $1.43B $1.12B $3.33B $2.19B
Cost of Revenue $902.8M $926.9M $716.4M $693.7M $648.5M $517.1M $1.93B $1.46B
Gross Profit $1.35B $1.18B $990.8M $869.4M $777.7M $603.6M $1.40B $729.4M
Gross Margin 59.8% 56.0% 58.0% 55.6% 54.5% 53.9% 42.1% 33.3%
Operating Expenses
Research & Development $120.3M $91.3M $75.3M $60.8M $49.1M $34.3M — —
SG&A Expense $1.07B $1.03B $830.3M $772.9M $665.8M $515.5M $1.13B $548.8M
Operating Income $-1.12B $-775.7M $-65.7M $-71.2M $-62.8M $-66.2M $203.6M $151.5M
Operating Margin -50.0% -36.8% -3.8% -4.6% -4.4% -5.9% 6.1% 6.9%
Interest Expense $34.8M $57.1M $19.7M $24.1M $29.1M $52.8M $119.5M $49.1M
Pretax Income $-1.16B $-822.9M $-67.1M $-2.1M $-121.8M $-119.0M $50.5M $92.4M
Income Tax Expense $22.3M $4.5M $-13.3M $36.1M $-19.5M $-44.6M $31.6M $-29.5M
Net Income $-1.18B $-825.5M $-33.3M $-13.3M $71.7M $42.6M $-527.6M $140.2M
Net Margin -52.7% -39.2% -1.9% -0.9% 5.0% 3.8% -15.9% 6.4%
EPS (Basic) $-20.75 $-14.93 $-0.61 $-0.25 $1.40 $0.93 $-3.89 $1.17
EPS (Diluted) $-20.75 $-14.93 $-0.61 $-0.25 $1.40 $0.93 $-3.89 $1.16
Shares Outstanding (Basic) 57.1M 55.3M 54.5M 54.1M 51.1M 45.6M 135.7M 120.3M
Shares Outstanding (Diluted) 57.1M 55.3M 54.5M 54.1M 51.1M 45.6M 136.7M 120.8M
Dividends Per Share — — — — — — — —
← Newer Page 1 of 3 Older →